Immunotherapy in head and neck cancer: Harnessing profit on a system disruption.

Abstract

Immune system deregulation and evasion play a key role in cancers' evolution and progression, including squamous cell carcinoma of the head and neck (SCCHN). Development of basic research proposed a whole new vision of cancer treatment, based on a strong biological rational, and targeting intrinsic deregulations. Immunotherapies provide an encouraging… (More)
DOI: 10.1016/j.oraloncology.2016.09.002

Topics

Cite this paper

@article{Rancoule2016ImmunotherapyIH, title={Immunotherapy in head and neck cancer: Harnessing profit on a system disruption.}, author={Chlo{\'e} Rancoule and Alexis Vallard and Sophie Espenel and J Guy and Yaoxiong Xia and Anis El Meddeb Hamrouni and Claire Rodriguez-Lafrasse and Cyrus Chargari and Eric Christopher Deutsch and Nicolas Magn{\'e}}, journal={Oral oncology}, year={2016}, volume={62}, pages={153-162} }